SALL1 and acute myeloid leukemia: In the THP1 group, mice engrafted with ctrl-GFP-SALL1 THP1 cells developed AML and died at an average of 6 weeks, about 9 weeks earlier compared to those injected with sh-SALL1 THP1 who developed AML and died at average of 16 weeks with a p value 0.0122.